Post-Acute Sequelae SARS-CoV-2 Infection (PASC)
Evaluation and Management in Adults Post-COVID-19
- Speaker:
- Paul Langlois, APN, PhD, CCRN, CCNS
- Duration:
- 1 Hour 36 Minutes
- Format:
- Audio and Video
- Copyright:
-
Apr 22, 2021
- Product Code:
- POS078235
- Media Type:
- Digital Seminar
Description
Long haulers. Post-COVID symptoms. Post-Acute Sequelae SARS-CoV-2 infection (PASC).
We are hearing different terminology, but one thing is evident….at least 1 in 3 patients are experiencing persistent symptoms after acute SARS-CoV-2 infection. Symptoms that are not explained by an alternative diagnosis.
These are not people who have been seriously ill in the hospital, but patients who are often physically fit, younger people who report persistent exercise intolerance, breathlessness and cough, anxiety, palpitations, “brain-fog” and poor concentration. This false boom and bust—the illusion of recovery only to fall back into mental and physical exhaustion – is the story of those with Post-Acute Sequelae SARS-CoV-2 infection.
While most people recover quickly and completely from the COVID-19 virus, stories of persistent and troubling symptoms have now moved from anecdote to the peer reviewed journals. Join me, Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN, a critical care clinical specialist, for a 90-minute presentation that will tackle what you must know today. Patients are coming to us with their questions. Those of us on the frontlines have them as well.
We will discuss actual case studies to feature evaluation of disease trajectory and the very latest treatments. I will provide references, current guidelines and patient education tools. As a healthcare provider, you are responsible to assess and manage your patient, regardless if it is a well-established or novel condition. You need the knowledge and resources to do that.
-Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN,
and the PESI Healthcare Team
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Post-Acute Sequelae SASCoV-2 Infection (4.8 MB) | Available after Purchase |
Speaker
Paul Langlois, APN, PhD, CCRN, CCNS Related seminars and products
Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.
Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.
His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.
Speaker Disclosures:
Financial: Dr. Paul Langlois has employment relationship with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Paul Langlois is a member of the American Nurses Association, the American Association of Critical Care Nurses, and the Society of Critical Care Medicine.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Distinguish the pathophysiology of COVID-19.
- Differentiate between symptoms of Post-Acute Sequelae SARS-CoV-2 infection (PASC) versus other undiagnosed conditions.
- Analyze the criteria for in- and out-patient management of PASC.
- Distinguish the mechanisms of action of PASC medications.
- Evaluate the mode of action of COVID-19 vaccine types (mRNA, viral vector, inactivated virus).
Outline
Pathophysiology of COVID-19
Post-COVID Symptoms: Post-Acute Sequelae SARS-CoV-2 infection (PASC)
-
Continuum of care
-
Post-COVID complications – CV, pulmonary, neurologic, neuro-cognitive, coagulation system, olfactory, functional status, psychological, dermatologic
-
Criteria for out-patient PACS management
Initial Assessment of the Patient with Suspected PASC
-
Self-evaluation tools
-
Telemedicine
-
Risk stratification
In-patient Management of PASC
-
Criteria for in-patient management
-
Investigational therapies
-
Medications approved by FDA
-
Supportive therapies
Out-patient Management of PASC
-
Criteria for out-patient management
-
Medications approved by FDA
-
Monoclonal antibodies
-
Inhaled steroids
-
New oral therapy
-
Antivirals
COVID-19 Vaccines: How Each Works
Target Audience
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...